FDA Person
FDAEric Mueller
View detailed information about Eric Mueller, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Eric Mueller, including their role, qualifications, and regulatory activities.
Recent Records (21)
Page 1 of 2483 - Haleon US Inc.
483
STATE_REFERRAL_LETTER - Infusion Partners, LLC
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Unknown Company
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Unknown Company
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Unknown Company
STATE_REFERRAL_LETTER
STATE_REFERRAL_LETTER - Infusience Inc
STATE_REFERRAL_LETTER
UNTITLED_LETTER - Resource Optimization & Innovation LLC
UNTITLED_LETTER
EIR - Hospira, Inc., A Pfizer Company
EIR
483 - Nebraska Methodist Hospital
483
WARNING_LETTER - Vi-Jon, LLC
WARNING_LETTER
EIR - Hospira, Inc., A Pfizer Company
EIR
WARNING_LETTER - Spartan Chemical Company, Inc.
WARNING_LETTER
STATE_REFERRAL_LETTER - ARJ Infusion Services Inc
STATE_REFERRAL_LETTER
483 - Bayer Healthcare Animal Health Inc
483
WARNING_LETTER - Apollo Care LLC
WARNING_LETTER
UNTITLED_LETTER - Jubilant Draximage Radiopharmacies Inc
UNTITLED_LETTER
483 - Haleon US Inc.
483
STATE_REFERRAL_LETTER - O'Brien Pharmacy
STATE_REFERRAL_LETTER
483 - Essential Pharmacy Compounding
483
EIR - Hospira, Inc., A Pfizer Company
EIR
Showing 1-20 of 21 records
Person Information
Name
Eric Mueller
ID: c2da0580-e8b7-41d8-94b6-3579d2bfad8b
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox